Current progress toward eradicating helicobacter pylori in east Asian countries: Differences in the 2013 revised guidelines between China, Japan, and South Korea

World Journal of Gastroenterology

Volumn 20, Issue 6, 2014, Pages 1493-1502

  Lee, Sun Young ^a  

^a Konkuk University School of Medicine   (South Korea)

Author keywords

Diagnosis; Eradication; Guideline; Helicobacter pylori; Treatment

Indexed keywords

ACETYLSALICYLIC ACID; AMOXICILLIN; BISMUTH; CIPROFLOXACIN; CLARITHROMYCIN; FLAVONOID; FURAZOLIDONE; GHRELIN; LEVOFLOXACIN; METRONIDAZOLE; PEPSINOGEN I; PEPSINOGEN II; PROBIOTIC AGENT; PROTON PUMP INHIBITOR; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL CLEARANCE; CHINA; CLINICAL TRIAL (TOPIC); DIAGNOSTIC TEST; GASTRITIS; GASTROESOPHAGEAL REFLUX; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; JAPAN; MARGINAL ZONE LYMPHOMA; PRACTICE GUIDELINE; SOUTH KOREA; STOMACH CANCER; UREA BREATH TEST; COMPLICATION; DISEASE ERADICATION; HELICOBACTER INFECTIONS; MICROBIOLOGY; PUBLIC HEALTH; STOMACH TUMOR;

CHINA; DISEASE ERADICATION; DRUG RESISTANCE, MICROBIAL; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; JAPAN; PRACTICE GUIDELINES AS TOPIC; PUBLIC HEALTH; REPUBLIC OF KOREA; STOMACH NEOPLASMS;

EID: 84893815498     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i6.1493     Document Type: Article

References (62)

1. Lee SY. Future candidates for indications of Helicobacter pylori eradication: do the indications need to be revised? J Gastroenterol Hepatol 2012; 27: 200-211 [PMID: 22098099 DOI: 10.1111/j.1440-1746.2011.06961.x]
2. Hu FL, Hu PJ, Liu WZ, De Wang J, Lv NH, Xiao SD, Zhang WD, Cheng H, Xie Y. Third Chinese National Consensus Report on the management of Helicobacter pylori infection. J Dig Dis 2008; 9: 178-184 [PMID: 18956598 DOI: 10.1111/ j.1751-2980.2008.00342.x]
3. Asaka M, Kato M, Takahashi S, Fukuda Y, Sugiyama T, Ota H, Uemura N, Murakami K, Satoh K, Sugano K. Guidelines for the management of Helicobacter pylori infection in Japan: 2009 revised edition. Helicobacter 2010; 15: 1-20 [PMID: 20302585 DOI: 10.1111/j.1523-5378.2009.00738.x]
4. Kim N, Kim JJ, Choe YH, Kim HS, Kim JI, Chung IS. [Diagnosis and treatment guidelines for Helicobacter pylori infection in Korea]. Korean J Gastroenterol 2009; 54: 269-278 [PMID: 19934608 DOI: 10.4166/kjg.2009.54.5.269]
5. Kim SG, Jung HK, Lee HL, Jang JY, Lee H, Kim CG, Shin WG, Shin ES, Lee YC. [Guidelines for the diagnosis and treatment of Helicobacter pylori infection in Korea, 2013 revised edition]. Korean J Gastroenterol 2013; 62: 3-26 [PMID: 23954956 DOI: 10.4166/kjg.2013.62.1.3]
6. Liu WZ, Xie Y, Cheng H, Lu NH, Hu FL, Zhang WD, Zhou LY, Chen Y, Zeng ZR, Wang CW, Xiao SD, Pan GZ, Hu PJ. Fourth Chinese National Consensus Report on the management of Helicobacter pylori infection. J Dig Dis 2013; 14: 211-221 [PMID: 23302262 DOI: 10.1111/1751-2980.12034]
7. Asaka M. A new approach for elimination of gastric cancer deaths in Japan. Int J Cancer 2013; 132: 1272-1276 [PMID: 23180638 DOI: 10.1002/ijc.27965]
8. Ji F, Wang ZW, Ning JW, Wang QY, Chen JY, Li YM. Effect of drug treatment on hyperplastic gastric polyps infected with Helicobacter pylori: a randomized, controlled trial. World J Gastroenterol 2006; 12: 1770-1773 [PMID: 16586550 DOI: 10.3748/wjg.v12.i11.1770]
9. Wang J, Xu L, Shi R, Huang X, Li SW, Huang Z, Zhang G. Gastric atrophy and intestinal metaplasia before and after Helicobacter pylori eradication: a meta-analysis. Digestion 2011; 83: 253-260 [PMID: 21282951 DOI: 10.1159/000280318]
10. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001; 345: 784-789 [PMID: 11556297 DOI: 10.1056/NEJMoa001999]
11. Yanaoka K, Oka M, Ohata H, Yoshimura N, Deguchi H, Mukoubayashi C, Enomoto S, Inoue I, Iguchi M, Maekita T, Ueda K, Utsunomiya H, Tamai H, Fujishiro M, Iwane M, Takeshita T, Mohara O, Ichinose M. Eradication of Helicobacter pylori prevents cancer development in subjects with mild gastric atrophy identified by serum pepsinogen levels. Int J Cancer 2009; 125: 2697-2703 [PMID: 19610064 DOI: 10.1002/ijc.24591]
12. Takenaka R, Okada H, Kato J, Makidono C, Hori S, Kawahara Y, Miyoshi M, Yumoto E, Imagawa A, Toyokawa T, Sakaguchi K, Shiratori Y. Helicobacter pylori eradication reduced the incidence of gastric cancer, especially of the intestinal type. Aliment Pharmacol Ther 2007; 25: 805-812 [PMID: 17373919 DOI: 10.1111/j.1365-2036.2007.03268.x]
13. Ogura K, Hirata Y, Yanai A, Shibata W, Ohmae T, Mitsuno Y, Maeda S, Watabe H, Yamaji Y, Okamoto M, Yoshida H, Kawabe T, Omata M. The effect of Helicobacter pylori eradication on reducing the incidence of gastric cancer. J Clin Gastroenterol 2008; 42: 279-283 [PMID: 18223496 DOI: 10.1097/01. mcg.0000248006.80699.7f]
14. Take S, Mizuno M, Ishiki K, Yoshida T, Ohara N, Yokota K, Oguma K, Okada H, Yamamoto K. The long-term risk of gastric cancer after the successful eradication of Helicobacter pylori. J Gastroenterol 2011; 46: 318-324 [PMID: 21103997 DOI: 10.1007/s00535-010-0347-9]
15. Fukase K, Kato M, Kikuchi S, Inoue K, Uemura N, Okamoto S, Terao S, Amagai K, Hayashi S, Asaka M. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet 2008; 372: 392-397 [PMID: 18675689 DOI: 10.1016/ S0140-6736(08)61159-9]
16. Ahn SY, Lee SY, Hong SN, Kim JH, Sung IK, Park HS, Shim CS, Jin CJ, Han HS. Endoscopic diagnosis of open-type atrophic gastritis is related to the histological diagnosis of intestinal metaplasia and Cdx2 expression. Dig Dis Sci 2011; 56: 1119-1126 [PMID: 21221798 DOI: 10.1007/s10620-010-1531-8]
17. Watari J, Das KK, Amenta PS, Tanabe H, Tanaka A, Geng X, Lin JJ, Kohgo Y, Das KM. Effect of eradication of Helicobacter pylori on the histology and cellular phenotype of gastric intestinal metaplasia. Clin Gastroenterol Hepatol 2008; 6: 409-417 [PMID: 18321787 DOI: 10.1016/j.cgh.2007.12.044]
18. Kato M, Asaka M. Recent knowledge of the relationship between Helicobacter pylori and gastric cancer and recent progress of gastroendoscopic diagnosis and treatment for gastric cancer. Jpn J Clin Oncol 2010; 40: 828-837 [PMID: 20736219 DOI: 10.1093/jjco/hyq119]
19. Kato M, Asaka M. Recent development of gastric cancer prevention. Jpn J Clin Oncol 2012; 42: 987-994 [PMID: 23018579 DOI: 10.1093/jjco/hys151]
20. Lee SY. Endoscopic gastritis: what does it mean? Dig Dis Sci 2011; 56: 2209-2211 [PMID: 21503678 DOI: 10.1007/s10620-011-1703-1]
21. Shimatani T, Inoue M, Iwamoto K, Hyogo H, Yokozaki M, Saeki T, Tazuma S, Horikawa Y, Harada N. Gastric acidity in patients with follicular gastritis is significantly reduced, but can be normalized after eradication for Helicobacter pylori. Helicobacter 2005; 10: 256-265 [PMID: 15904484 DOI: 10.1111/ j.1523-5378.2005.00318.x]
22. Choi HJ, Lee SY, Lee JH, Seol DC, Kim SY, Choi HJ, Park HS, Hong SN, Han HS. Two atypical cases of nodular gastritis: a poorly differentiated gastric adenocarcinoma and a pseudolow grade gastric MALT lymphoma. Gastroenterol Res 2010; 3: 41-45 [DOI: 10.4021/gr2010.02.170w]
23. Nishibayashi H, Kanayama S, Kiyohara T, Yamamoto K, Miyazaki Y, Yasunaga Y, Shinomura Y, Takeshita T, Takeuchi T, Morimoto K, Matsuzawa Y. Helicobacter pyloriinduced enlarged-fold gastritis is associated with increased mutagenicity of gastric juice, increased oxidative DNA damage, and an increased risk of gastric carcinoma. J Gastroenterol Hepatol 2003; 18: 1384-1391 [PMID: 14675267 DOI: 10.1046/j.1440-1746.2003.03192.x]
24. Miyazaki T, Murayama Y, Shinomura Y, Yamamoto T, Watabe K, Tsutsui S, Kiyohara T, Tamura S, Hayashi N. E-cadherin gene promoter hypermethylation in H. pylori-induced enlarged fold gastritis. Helicobacter 2007; 12: 523-531 [PMID: 17760721 DOI: 10.1111/j.1523-5378.2007.00519.x]
25. Shin CM, Kim N, Yang HJ, Cho SI, Lee HS, Kim JS, Jung HC, Song IS. Stomach cancer risk in gastric cancer relatives: interaction between Helicobacter pylori infection and family history of gastric cancer for the risk of stomach cancer. J Clin Gastroenterol 2010; 44: e34-e39 [PMID: 19561529 DOI: 10.1097/MCG.0b013e3181a159c4]
26. Nam JH, Choi IJ, Cho SJ, Kim CG, Lee JY, Nam SY, Park SR, Kook MC, Nam BH, Kim YW. Helicobacter pylori infection and histological changes in siblings of young gastric cancer patients. J Gastroenterol Hepatol 2011; 26: 1157-1163 [PMID: 21392104 DOI: 10.1111/j.1440-1746.2011.06717.x]
27. Chang YW, Han YS, Lee DK, Kim HJ, Lim HS, Moon JS, Dong SH, Kim BH, Lee JI, Chang R. Role of Helicobacter pylori infection among offspring or siblings of gastric cancer patients. Int J Cancer 2002; 101: 469-474 [PMID: 12216076 DOI: 10.1002/ijc.10637]
28. Kang JM, Kim N, Shin CM, Lee HS, Lee DH, Jung HC, Song IS. Predictive factors for improvement of atrophic gastritis and intestinal metaplasia after Helicobacter pylori eradication: a three-year follow-up study in Korea. Helicobacter 2012; 17: 86-95 [PMID: 22404438 DOI: 10.1111/ j.1523-5378.2011.00918.x]
29. Lee SY, Park HS, Yu SK, Sung IK, Jin CJ, Choe WH, Kwon SY, Lee CH, Choi KW. Decreasing prevalence of Helicobacter pylori infection: a 9-year observational study. Hepatogastroenterology 2007; 54: 630-633 [PMID: 17523338]
30. Seo TH, Lee SY, Uchida T, Fujioka T, Jin CJ, Hwang TS, Han HS. The origin of non-H. pylori-related positive Giemsa staining in human gastric biopsy specimens: A prospective study. Dig Liver Dis 2011; 43: 23-27 [PMID: 20483675 DOI: 10.1016/j.dld.2010.04.006]
31. Kim SE, Park YS, Kim N, Kim MS, Jo HJ, Shin CM, Lee SH, Hwang JH, Kim JW, Jeong SH, Lee DH, Jung HC. Effect of Helicobacter pylori Eradication on Functional Dyspepsia. J Neurogastroenterol Motil 2013; 19: 233-243 [PMID: 23667755 DOI: 10.5056/jnm.2013.19.2.233]
32. Suzuki H, Nishizawa T, Hibi T. Can Helicobacter pylori-associated dyspepsia be categorized as functional dyspepsia? J Gastroenterol Hepatol 2011; 26 Suppl 3: 42-45 [PMID: 21443708 DOI: 10.1111/j.1440-1746.2011.06629.x]
33. Lee SY, Tang SJ, Rockey DC, Weinstein D, Lara L, Sreenarasimhaiah J, Choi KW. Managing anticoagulation and antiplatelet medications in GI endoscopy: a survey comparing the East and the West. Gastrointest Endosc 2008; 67: 1076-1081 [PMID: 18384789 DOI: 10.1016/j.gie.2007.11.037]
34. Lee SY. Differences in managing anticoagulants and antiplatelets for gastrointestinal endoscopy between East and West. Gastroenterol Res 2009; 2: 67-80 [DOI: 10.4021/ gr2009.04.1283]
35. Kuipers EJ, Lundell L, Klinkenberg-Knol EC, Havu N, Festen HP, Liedman B, Lamers CB, Jansen JB, Dalenback J, Snel P, Nelis GF, Meuwissen SG. Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. N Engl J Med 1996; 334: 1018-1022 [PMID: 8598839 DOI: 10.1056/ NEJM199604183341603]
36. Song HJ, Kwon JW, Kim N, Park YS. Cost Effectiveness Associated with Helicobacter pylori Screening and Eradication in Patients Taking Nonsteroidal Anti-Inflammatory Drugs and/or Aspirin. Gut Liver 2013; 7: 182-189 [PMID: 23560154 DOI: 10.5009/gnl.2013.7.2.182]
37. Cai W, Zhou L, Ren W, Deng L, Yu M. Variables influencing outcome of Helicobacter pylori eradication therapy in South China. Helicobacter 2009; 14: 91-96 [PMID: 19751433 DOI: 10.1111/j.1523-5378.2009.00718.x]
38. Su P, Li Y, Li H, Zhang J, Lin L, Wang Q, Guo F, Ji Z, Mao J, Tang W, Shi Z, Shao W, Mao J, Zhu X, Zhang X, Tong Y, Tu H, Jiang M, Wang Z, Jin F, Yang N, Zhang J. Antibiotic resistance of Helicobacter pylori isolated in the Southeast Coastal Region of China. Helicobacter 2013; 18: 274-279 [PMID: 23418857 DOI: 10.1111/hel.12046]
39. Sun QJ, Liang X, Zheng Q, Gu WQ, Liu WZ, Xiao SD, Lu H. Resistance of Helicobacter pylori to antibiotics from 2000 to 2009 in Shanghai. World J Gastroenterol 2010; 16: 5118-5121 [PMID: 20976850 DOI: 10.3748/wjg.v16.i40.5118]
40. Sun Q, Liang X, Zheng Q, Liu W, Xiao S, Gu W, Lu H. High efficacy of 14-day triple therapy-based, bismuth-containing quadruple therapy for initial Helicobacter pylori eradication. Helicobacter 2010; 15: 233-238 [PMID: 20557366 DOI: 10.1111/ j.1523-5378.2010.00758.x]
41. Lin J, Huang WW. A systematic review of treating Helicobacter pylori infection with Traditional Chinese Medicine. World J Gastroenterol 2009; 15: 4715-4719 [PMID: 19787835 DOI: 10.3748/wjg.15.4715]
42. Horiki N, Omata F, Uemura M, Suzuki S, Ishii N, Iizuka Y, Fukuda K, Fujita Y, Katsurahara M, Ito T, Cesar GE, Imoto I, Takei Y. Annual change of primary resistance to clarithromycin among Helicobacter pylori isolates from 1996 through 2008 in Japan. Helicobacter 2009; 14: 86-90 [PMID: 19751432 DOI: 10.1111/j.1523-5378.2009.00714.x]
43. Shimoyama T, Fukuda S, Mikami T, Fukushi M, Munakata A. Efficacy of metronidazole for the treatment of clarithromycin-resistant Helicobacter pylori infection in a Japanese population. J Gastroenterol 2004; 39: 927-930 [PMID: 15549444 DOI: 10.1007/s00535-004-1424-8]
44. Shiota S, Murakawi K, Suzuki R, Fujioka T, Yamaoka Y. Helicobacter pylori infection in Japan. Expert Rev Gastroenterol Hepatol 2013; 7: 35-40 [PMID: 23265147 DOI: 10.1586/ egh.12.67]
45. Lee SY, Shin YW, Hahm KB. Phytoceuticals: mighty but ignored weapons against Helicobacter pylori infection. J Dig Dis 2008; 9: 129-139 [PMID: 18956590 DOI: 10.1111/ j.1751-2980.2008.00334.x]
46. Lee BH, Kim N, Hwang TJ, Lee SH, Park YS, Hwang JH, Kim JW, Jeong SH, Lee DH, Jung HC, Song IS. Bismuthcontaining quadruple therapy as second-line treatment for Helicobacter pylori infection: effect of treatment duration and antibiotic resistance on the eradication rate in Korea. Helicobacter 2010; 15: 38-45 [PMID: 20302588 DOI: 10.1111/ j.1523-5378.2009.00735.x]
47. Lee JW, Kim N, Kim JM, Nam RH, Chang H, Kim JY, Shin CM, Park YS, Lee DH, Jung HC. Prevalence of primary and secondary antimicrobial resistance of Helicobacter pylori in Korea from 2003 through 2012. Helicobacter 2013; 18: 206-214 [PMID: 23241101 DOI: 10.1111/hel.12031]
48. Lee YC, Lee SY, Pyo JH, Kwon DH, Rhee JC, Kim JJ. Isogenic variation of Helicobacter pylori strain resulting in heteroresistant antibacterial phenotypes in a single host in vivo. Helicobacter 2005; 10: 240-248 [PMID: 15904482 DOI: 10.1111/ j.1523-5378.2005.00316.x]
49. Take S, Mizuno M, Ishiki K, Imada T, Okuno T, Yoshida T, Yokota K, Oguma K, Kita M, Okada H, Yamamoto K. Reinfection rate of Helicobacter pylori after eradication treatment: a long-term prospective study in Japan. J Gastroenterol 2012; 47: 641-646 [PMID: 22350696 DOI: 10.1007/ s00535-012-0536-9]
50. Yan TL, Hu QD, Zhang Q, Li YM, Liang TB. National rates of Helicobacter pylori recurrence are significantly and inversely correlated with human development index. Aliment Pharmacol Ther 2013; 37: 963-968 [PMID: 23550618 DOI: 10.1111/apt.12293]
51. Lee JH, Kim N, Chung JI, Kang KP, Lee SH, Park YS, Hwang JH, Kim JW, Jeong SH, Lee DH, Jung HC, Song IS. Longterm follow up of Helicobacter pylori IgG serology after eradication and reinfection rate of H. pylori in South Korea. Helicobacter 2008; 13: 288-294 [PMID: 18665939 DOI: 10.1111/ j.1523-5378.2008.00616.x]
52. Kim MS, Kim N, Kim SE, Jo HJ, Shin CM, Lee SH, Park YS, Hwang JH, Kim JW, Jeong SH, Lee DH, Kim JM, Jung HC. Long-term follow-up Helicobacter pylori reinfection rate and its associated factors in Korea. Helicobacter 2013; 18: 135-142 [PMID: 23066652 DOI: 10.1111/hel.12018]
53. Shiotani A, Uedo N, Iishi H, Tatsuta M, Ishiguro S, Nakae Y, Kamada T, Haruma K, Merchant JL. Re-expression of sonic hedgehog and reduction of CDX2 after Helicobacter pylori eradication prior to incomplete intestinal metaplasia. Int J Cancer 2007; 121: 1182-1189 [PMID: 17520681 DOI: 10.1002/ ijc.22835]
54. Shin WG, Kim HU, Song HJ, Hong SJ, Shim KN, Sung IK, Kim JG. Surveillance strategy of atrophic gastritis and intestinal metaplasia in a country with a high prevalence of gastric cancer. Dig Dis Sci 2012; 57: 746-752 [PMID: 21984437 DOI: 10.1007/s10620-011-1919-0]
55. Hirata K, Suzuki H, Matsuzaki J, Masaoka T, Saito Y, Nishizawa T, Iwasaki E, Fukuhara S, Okada S, Hibi T. Improvement of reflux symptom related quality of life after Helicobacter pylori eradication therapy. J Clin Biochem Nutr 2013; 52: 172-178 [PMID: 23524980 DOI: 10.3164/jcbn.12-107]
56. Nam SY, Choi IJ, Ryu KH, Kim BC, Kim CG, Nam BH. Effect of Helicobacter pylori infection and its eradication on reflux esophagitis and reflux symptoms. Am J Gastroenterol 2010; 105: 2153-2162 [PMID: 20571493 DOI: 10.1038/ajg.2010.251]
57. Take S, Mizuno M, Ishiki K, Nagahara Y, Yoshida T, Yokota K, Oguma K, Okada H, Yamamoto K. Helicobacter pylori eradication may induce de novo, but transient and mild, reflux esophagitis: Prospective endoscopic evaluation. J Gastroenterol Hepatol 2009; 24: 107-113 [PMID: 18823429 DOI: 10.1111/j.1440-1746.2008.05606.x]
58. Kim N, Lee SW, Kim JI, Baik GH, Kim SJ, Seo GS, Oh HJ, Kim SW, Jeong H, Hong SJ, Shim KN, Shin JE, Park SJ, Im EH, Park JJ, Cho SI, Jung HC. Effect of Helicobacter pylori Eradication on the Development of Reflux Esophagitis and Gastroesophageal Reflux Symptoms: A Nationwide MultiCenter Prospective Study. Gut Liver 2011; 5: 437-446 [PMID: 22195241 DOI: 10.5009/gnl.2011.5.4.437]
59. Qian B, Ma S, Shang L, Qian J, Zhang G. Effects of Helicobacter pylori eradication on gastroesophageal reflux disease. Helicobacter 2011; 16: 255-265 [PMID: 21762264 DOI: 10.1111/ j.1523-5378.2011.00846.x]
60. Weigt J, Malfertheiner P. Influence of Helicobacter pylori on gastric regulation of food intake. Curr Opin Clin Nutr Metab Care 2009; 12: 522-525 [PMID: 19584718 DOI: 10.1097/ MCO.0b013e32832eb56e]
61. Lee ES, Yoon YS, Park CY, Kim HS, Um TH, Baik HW, Jang EJ, Lee S, Park HS, Oh SW. Eradication of Helicobacter pylori increases ghrelin mRNA expression in the gastric mucosa. J Korean Med Sci 2010; 25: 265-271 [PMID: 20119581 DOI: 10.3346/jkms.2010.25.2.265]
62. Jang EJ, Park SW, Park JS, Park SJ, Hahm KB, Paik SY, Sin MK, Lee ES, Oh SW, Park CY, Baik HW. The influence of the eradication of Helicobacter pylori on gastric ghrelin, appetite, and body mass index in patients with peptic ulcer disease. J Gastroenterol Hepatol 2008; 23 Suppl 2: S278-S285 [PMID: 19120912 DOI: 10.1111/j.1440-1746.2008.05415.x]